Technology encourages millennial entrepreneurs to craft innovative medical solutions, which take the industry to the next level.
FREMONT, CA: Medical Innovations play a crucial role in improving wellness, and to build a better world, medical professionals continually tend to discover possibilities with available technological aid. The data-driven digital world offers high-tech solutions and innovative supports for medical needs from personalized medicines to the device tracking and monitoring abilities. Today, high-class healthcare facilities attract investors across the globe to invest and improve the medical services for more efficiencies and cost-effectiveness. The emergence of technology transforms care delivery and influences the minds of the entrepreneurs to develop and innovate smart medical aid. Here are numerous inventions and on-going projects available to contribute to the different segments of the medical field.
Anatomi Corp. focuses on the discovery of new treatments for neurological diseases. The company develops tools for manufacturing human neurons from stem cells faster the pharmaceutical discovery across the different scientific field. Anatomi’s innovation provides a way to develop neurons of diseased patients and more efficiently. The technology leverages the potential of neuroscience development, accelerates, and allows the professionals to study the specific nature of the disease in different patients. It offers an advancement of fundamental understanding of the neural and genuine human neural network, neuron-glia interactions, and neurodegeneration. The revolutionary company missions to understand, prevent, and treat dysfunction of the human nervous system.
USA-based startups, Organovo, and Nanofiber Solutions contribute to the development of artificial organs. Organovo specialized to design and create functional human tissues, raises funding of $43.7 million from the market. It uses proprietary 3D bioprinting technology to enable the reproduction of 3D tissues, which accurately represents the human biology. Organovo goals to build living tissues that can function like native tissues. Likewise, Nanofiber Solutions designs and manufactures 3D Nanofiber scaffolds, a mimic of extracellular matrix within the body. The platform technology carries the capabilities to perform successfully in a realistic environment, regardless in the body or on a lab bench.
Adding more to artificial organ development, InSphero sets standards on 3D cell technology by successfully able to engineer all human liver types and replicate the progression on Non-Alcoholic Steatohepatitis (NASH) in patients.
Novel collaboration between Emulate and AstraZeneca embed its organs-on-chips technology. The provided artificial organ contains a hollow channel, lined with thousands of living human cells and tissues, which recreate natural physiology and mechanical forces within the human body.
A multi-disciplinary research and development lab, the Human Interface Technology Lab (HITLab) raises funds equivalent to $5 million, to represent deep learning and developments around human interface technology. The company combines different technical advantages of engineering, education, social sciences, architecture, and design arts for a new direction in the medical discipline.
Osso VR provides clinically validated surgical training platform, designed for all the skill level, including surgeons, sales teams, and hospital staffs. Raising $2 million, the company develops the product with highly realistic hand-based interactions. It creates an immersive training environment containing cutting-edge procedures and devices.
EchoPixel raises $14.3 million to develop interactive 3D medical visualization software. It allows the medical professionals to interact with patient-specific organs and tissues in an open 3D emanating from a display, enabling doctors to identify immediately, evaluate, and dissect clinically significant structures.
Meridiun, founded in 2017, creates a mobile application called AR+. It allows the clinician to deploy simulated medical content through audio, video, 3D imagery, training, and more. It displays augmented reality and runs on smartphone and tablets.
Big Data and Artificial Intelligence
INTelico Therapeutics is licensed for a newly developed computer program, which integrates genetic information of millions of patients and medical researchers. With big data, the program builds groups based on individual genetic makeup and responses to various medications. The access to genetic data helps it to align in the historical group and predicts the progress of diseases for individuals, including the reaction towards therapies. The company has licensed drug target discovery and precision therapeutics, which is based upon probabilistic models of disease. The novel computational algorithm uses technologies like Machine Learning (ML), Artificial Intelligence (AI), and big data analysis. INTelico Therapeutics aims to run bioinformatics on the proprietary data for the further development of new and more effective drugs quickly and cost-effectively.
With the funding of $13 million, Thync develops wearable “pod,” which uses neuro-stimulation to combat stress and promotes better sleep. The company’s lead product, Thync Relax Pro activates nerve pathways in the head and neck by using low levels of electric stimulation.
Aiming to provide a safe way for paralyzed patients to control of mobility–assistive device, Synchron develops Stentrode, an implantable device. It involves a small and flexible device, which can pass through cerebral blood vessels and implant in the brain to interpret the electrical data emitted by neurons. Currently, the company prepares for early-stage clinical trials to evaluate device safety and feasibility.
To treat depression, Flow Neuroscience uses brain stimulation through an advanced headset. It delivers transcranial Direct Current Stimulation (tDCS) to reverse neural activity imbalances in the frontal lobe. The device pairs with a smartphone app and guides the user through a 6-week wellness program.
An innovative solution by Paradromics is the implantable brain device to help patients with disabilities, such as blindness. It focuses on neurological brain-machine interfaces, which can improve the patients’ navigation and interaction around the world. Founded in 2015, the company has successfully raised $27.4 million.
InsightRX, a startup incorporates the principle of quantitative pharmacology and machine learning to offer personalized medicine to the patients. It uses predictive analytics, which enables the doctor to make decisions based on demographics, biomarkers, genetics, and drug levels.
Encellin develops implantable devices to monitor patients and alert for medicine intake dose remotely. It offers a thin-film cell encapsulation device for cell-based therapeutics and provides a long-term auto-regulation therapeutic solution without recharge or any need to refill.
Celcuity, a biotech company provides cell-based assay using a cellular analysis platform. It helps to identify the best-suited drug for specific patients and their disease. Access to the cellular level offers clinicians and pharmaceutical companies a unique insight into the patient's response to drug therapy.
Digital platforms and solutions in the medical care sector frame a picture of next-generation facilities. In recent years, technology has touched all the areas in the medical industry, which provides assistance from diagnosis to treatment, and encourages patient-centric care. For the new generation's tech-savvy patients, medical professionals and experts are widely accepting the technological advantages and rapidly achieving performance goals. Innovations in medical treatment make way for precision treatment, along with smart, instant, and cost-effective solutions for both the patients and doctors.